{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "1314001",
  "DateCompleted": {
    "Year": "1992",
    "Month": "05",
    "Day": "11"
  },
  "DateRevised": {
    "Year": "2019",
    "Month": "09",
    "Day": "11"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0165-6147",
      "JournalIssue": {
        "Volume": "13",
        "Issue": "2",
        "PubDate": {
          "Year": "1992",
          "Month": "Feb"
        }
      },
      "Title": "Trends in pharmacological sciences",
      "ISOAbbreviation": "Trends Pharmacol Sci"
    },
    "ArticleTitle": "Multiple benzodiazepine receptors: no reason for anxiety.",
    "Pagination": {
      "StartPage": "76",
      "EndPage": "81",
      "MedlinePgn": "76-81"
    },
    "Abstract": {
      "AbstractText": [
        "Since the introduction of the benzodiazepines into clinical practice in 1960, these drugs have been widely employed as anxiolytics, sedative/hypnotics and anticonvulsants. In recent years, concern has been expressed about their side-effects, and their use has declined. During this latter period many advances have been made in understanding the molecular mechanisms by which these drugs produce their effects. Adam Doble and Ian Martin review this progress and highlight the possibilities that these advances may hold for the development of more efficacious and specific medicines."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Neurochemistry Department at Rh\u00f4ne-Poulenc Rorer, Centre de Recherche de Vitry-Alfortville, Vitry sur Seine, France."
          }
        ],
        "LastName": "Doble",
        "ForeName": "A",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Martin",
        "ForeName": "I L",
        "Initials": "IL"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Trends Pharmacol Sci",
    "NlmUniqueID": "7906158",
    "ISSNLinking": "0165-6147"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Receptors, GABA-A"
    }
  ],
  "CommentsCorrectionsList": [
    {
      "RefSource": "Trends Pharmacol Sci 1992 Mar;13(3):86"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [
        "drug therapy",
        "psychology"
      ],
      "DescriptorName": "Anxiety"
    },
    {
      "QualifierName": [
        "drug effects",
        "physiology"
      ],
      "DescriptorName": "Brain Chemistry"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Receptors, GABA-A"
    }
  ],
  "NumberOfReferences": "47"
}